SCHEMBL4932367

SCHEMBL4932367

O=C(/C=C/c1ccc(CN2CCN(C(=O)NC(=O)c3ccccc3)CC2)cc1)NO

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 13/20 0.62
HDAC4 P56524 12/20 0.62
HDAC3 O15379 11/20 0.62
HDAC7 Q8WUI4 11/20 0.62
HDAC2 Q92769 11/20 0.62
HDAC10 Q969S8 11/20 0.62
HDAC11 Q96DB2 11/20 0.62
HDAC8 Q9BY41 11/20 0.62
HDAC6 Q9UBN7 11/20 0.62
HDAC9 Q9UKV0 11/20 0.62
HDAC5 Q9UQL6 11/20 0.62
FAAH O00519 1/20 0.57
ALDH1A1 P00352 1/20 0.55
GPR183 P32249 2/20 0.55
KCNH2 Q12809 2/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
DRD4 P21917 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932374 1.00 HDAC1 (0.62) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL726203 0.86 KDM4E (0.62) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL1486851 0.86 KDM4E (0.62) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL4925003 0.85 HDAC1 (0.75) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL1486886 0.85 HDAC1 (0.69) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL724056 0.85 HDAC1 (0.69) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL724438 0.82 HDAC1 (0.65) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL12152498 0.82 LMNA (0.67) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL30887590 0.81 HDAC1 (0.63) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL1481725 0.81 HDAC1 (0.80) HDAC1HDAC4HDAC3HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US claimed
EP-1685094-A4 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S BIO PTE LTD (SG) 2007-08-22 EP claimed
EP-1685094-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*Bio Pte Ltd (SG) 2006-08-02 EP claimed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO claimed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
EP-1685094-A4 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S BIO PTE LTD (SG) 2007-08-22 EP disclosed
EP-1685094-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*Bio Pte Ltd (SG) 2006-08-02 EP disclosed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO disclosed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 HDAC1 1/4885HDAC4 3/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.